Vanguard Capital Management
LUNG icon

Vanguard Capital Management’s Pulmonx LUNG Stock Holding History

Vanguard Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
1,630,219
-4,045
-0.2% -$5.57K ﹤0.01% 3404
2026
Q1 		$2.11M Buy
+1,634,264
New +$2.7M ﹤0.01% 3347

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management's LUNG Position: Q2 2026 in Review

Vanguard Capital Management reduced its Pulmonx (LUNG) stake by 0.25% in Q2 2026, selling an estimated $5.57K and leaving 1,630,219 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

Vanguard Capital Management first reported a position in LUNG in Q1 2026 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Vanguard Capital Management held 1,630,219 shares of Pulmonx worth $2.12M as of Q2 2026.
  • Vanguard Capital Management sold 4,045 Pulmonx shares in Q2 2026, an estimated $5.57K.
  • Pulmonx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3404 holding.
  • Vanguard Capital Management first reported a position in Pulmonx in Q1 2026 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.